Javascript must be enabled to continue!
Lung Protective Effects of Esketamine in Patients undergoing video-assisted thoracoscopic surgery:A randomized controlled trial
View through CrossRef
Abstract
Background
Video-assisted thoracic surgery (VATS) is associated with pulmonary function impairment on account of the specificity of the surgical site.Recent studies have reported that the widespread application of esketamine in general anesthesia.Esketamine acts on multiple receptors but the role in pulmonary protection is indeterminate.Hence,we hypothesized that esketamine exerts protective effects on pulmonary function in patients undergoing VATS and further investigate the possible mechanisms and determine the effects of different dosages.
Methods
Patients with aged 18–65 years scheduled for VATS were included in this study.The patients were assigned randomly to 3 groups as follows:esketamine was administered in group K1 as an initial loading bolus of 0.5 mg/kg before induction and followed by a maintenance infusion of 0.5 mg/kg/h during surgery,patients in group K2 received esketamine as an initial loading bolus of 1.0 mg/kg before induction and followed by 0.5 mg/kg/h during surgery.And group C was received identical amount of normal saline as a placebo.
Results
In total,85 eligible patients were enrolled in our study.Patients in the placebo group had lower a/A ratio and OI,higher RI and A-aDO2 when discharged from ICU and 24h postoperatively (all p༜0.05),higher incidence of postoperative pulmonary complications (PPCs)(p = 0.017),higher resting and movement numerical rating scale (NRS) at 24h and 48h postoperatively,greater fluctuations of blood pressure and heart rate intraoperatively compared with the esketamine groups.while the time of tracheal extubation,length of intensive care unit stay,the serum levels of procalcitonin (PCT) and the incidence of postoperative adverse events were similar among the 3 groups.
Conclusions
Esketamine administration was effective in protecting pulmonary function in patients undergoing VATS by improving oxygenation,reducing hemodynamic fluctuation and postoperative pain.But the relationship between the optimal dosage and minimal adverse events needed further researches.
Title: Lung Protective Effects of Esketamine in Patients undergoing video-assisted thoracoscopic surgery:A randomized controlled trial
Description:
Abstract
Background
Video-assisted thoracic surgery (VATS) is associated with pulmonary function impairment on account of the specificity of the surgical site.
Recent studies have reported that the widespread application of esketamine in general anesthesia.
Esketamine acts on multiple receptors but the role in pulmonary protection is indeterminate.
Hence,we hypothesized that esketamine exerts protective effects on pulmonary function in patients undergoing VATS and further investigate the possible mechanisms and determine the effects of different dosages.
Methods
Patients with aged 18–65 years scheduled for VATS were included in this study.
The patients were assigned randomly to 3 groups as follows:esketamine was administered in group K1 as an initial loading bolus of 0.
5 mg/kg before induction and followed by a maintenance infusion of 0.
5 mg/kg/h during surgery,patients in group K2 received esketamine as an initial loading bolus of 1.
0 mg/kg before induction and followed by 0.
5 mg/kg/h during surgery.
And group C was received identical amount of normal saline as a placebo.
Results
In total,85 eligible patients were enrolled in our study.
Patients in the placebo group had lower a/A ratio and OI,higher RI and A-aDO2 when discharged from ICU and 24h postoperatively (all p༜0.
05),higher incidence of postoperative pulmonary complications (PPCs)(p = 0.
017),higher resting and movement numerical rating scale (NRS) at 24h and 48h postoperatively,greater fluctuations of blood pressure and heart rate intraoperatively compared with the esketamine groups.
while the time of tracheal extubation,length of intensive care unit stay,the serum levels of procalcitonin (PCT) and the incidence of postoperative adverse events were similar among the 3 groups.
Conclusions
Esketamine administration was effective in protecting pulmonary function in patients undergoing VATS by improving oxygenation,reducing hemodynamic fluctuation and postoperative pain.
But the relationship between the optimal dosage and minimal adverse events needed further researches.
Related Results
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Esketamine: Less Drowsiness, More Analgesia
Esketamine: Less Drowsiness, More Analgesia
Racemic ketamine is a 1:1 mixture of 2 enantiomers that turn light in opposite direction: Dextrorotatory esketamine is approximately 4 times more affine for the N-methyl-D-aspartat...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Effect of Esketamine Combined with Sufentanil-Based Patient-Controlled Intravenous Analgesia on Postoperative Pain in Elderly Total Hip Arthroplasty Patients: A Three-Arm Randomized Trial
Effect of Esketamine Combined with Sufentanil-Based Patient-Controlled Intravenous Analgesia on Postoperative Pain in Elderly Total Hip Arthroplasty Patients: A Three-Arm Randomized Trial
Background: Total hip arthroplasty (THA) is a common procedure for end-stage hip disorders, yet postoperative pain management remains challenging due to opioid-related complication...
Impact of history of esketamine treatment in the current depressive episode on response to iTBS
Impact of history of esketamine treatment in the current depressive episode on response to iTBS
IntroductionAn increasing number of patients with treatment-resistant depression (TRD) are treated with a novel form of transcranial magnetic stimulation (TMS): the intermittent th...
Surgical Treament of the Patients with Pulmonary Tuberculosis using Videothoracoscopic Interventions
Surgical Treament of the Patients with Pulmonary Tuberculosis using Videothoracoscopic Interventions
Introduction. Pulmonary tuberculosis is a serious problem as in Ukraine as throughout the world. The number of patients with pulmonary tuberculosis is increasing year by year, whic...
Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)
Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)
IntroductionNMDA-Receptor antagonists have rapid antidepressant and antisuicidal properties. However, the antidepressant effect is short lasting raising the question of best mainte...
Efficacy and Safety of Esketamine in Patients Undergoing Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Efficacy and Safety of Esketamine in Patients Undergoing Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Laparoscopic cholecystectomy is the gold standard for gallbladder disease but is often associated with significant postoperative pain. Opioid analgesia is effective and...

